Patent · US Active

IAP BIR domain binding compounds

US7645741B2 · kind B2 · utility

3Cited by
6References
47Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2007
Grant dateJan 12, 2010
Priority date
Expiry dateNov 1, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I or IIor a salt thereof, in which R1, R2, R3, R100, R200, R300, A, A1, BG, Q and Q1 are substituents described herein. Also disclosed is the use of compounds of Formula I and II to treat proliferative disorders such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.